SynBioVen is an early-stage biotech investment vehicle focused on supporting the next generation of synthetic biology scientists, founders and start-ups. Launched in 2022, it provides PoC, pre-seed and seed funding along with technical expertise to accelerate ventures. The company envisions synthetic biology as a driver of the next industrial revolution and a net-zero economy, with the UK playing a leading role. It offers access to a West London R&D hub and collaborates with partners like SynBiCITE and the London Biofoundry to help de-risk and scale portfolio companies.
No recent news for this company.
No recent deals for this company.